Canada’s immigration department has released its latest processing times update for various application types, including ...

FDA accepted a new drug application for tirabrutinib in relapsed or refractory PCNSL.

Ava Westenfelder ’28 recently travelled to Germany and Austria for a three-week study abroad program. Learn all about her trip and reflection below. Trip Favorites Food: Schnitzel City: Salzburg, ...

The U.S. Food and Drug Administration (FDA) has accepted a new drug application for iberdomide combined with Darzalex (daratumumab) and dexamethasone (IberDd) for the treatment of patients with ...

Scientists successfully borrow concepts from string theory to explain the network architecture of branching biological systems like neurons ...

The regulator is going to look at the consequences of broad application of these methods for the economy and its structure, innovations and productivity, the labor market and inequality across househo ...

Year Study Shows Mobile Issues Regularly Stop Frontline Work While Remaining Largely Invisible to IT Frontline work ...

Drug observers puzzled by vaccine maker, which made a killing on COVID-19, failing to read the room with new administration. Moderna puts heat on FDA vaccines chief who's already been rebuked once by ...

Brazilian scientists have made advances in an area recognized by the 2025 Nobel Prize in Chemistry: the development and application of metal-organic frameworks (MOFs). These are porous crystalline ...

Moderna’s mRNA influenza vaccine faces US regulatory delays after a refusal-to-file letter from top FDA official Dr Vinay Prasad.

HealthDay News — In a major blow to vaccine development, the US Food and Drug Administration (FDA) said it will not review Moderna’s application for the first mRNA-based flu shot. Dr Vinay Prasad, the ...